Heparin Market 2027 By Type, Route of Administration, Application, End User | The Insight Partners

Heparin Market to 2027 - Global Analysis and Forecasts by Type (Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin); Route of Administration (Intravenous, Subcutaneous); Application (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Others); End User (Hospitals, Blood and stem cell banks, Others)

Report Code: TIPRE00006205 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Heparin is a blood thinner or disaccharide anticoagulant which prevents the formation of blood clots and is produced in the body by mast cells and basophils. It is a naturally occurring anticoagulant released from mast cells. Heparin is also known as Unfractionated heparin (UH) is a heterogeneous preparation of anionic, sulfated glycosaminoglycan polymer. Its mechanism of action includes binding reversibly to antithrombin III (ATIII) and significantly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin (factor IIa) and factor Xa.

MARKET DYNAMICS

The heparin market is anticipated to grow in the forecast, rising cases of conditions such as coronary heart disease, pulmonary embolism and deep vein thrombosis. Myocardial infarction (MI) is one of the major complications of coronary heart disease. In addition, increasing number of accidents and surgeries is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Heparin Market Analysis to 2027" is a specialized and in-depth study of the in pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of heparin market with detailed market segmentation by type, by route of administration, by application, end user and geography. The global heparin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading heparin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global heparin market is segmented on the basis of type, by route of administration, by application, end user. Based on type, market is segmented low molecular weight heparin, ultra-low molecular weight heparin and unfractionated heparin. The heparin market is categorized based on route of administration in Intravenous and Subcutaneous. By application the market is segmented into venous thromboembolism, atrial fibrillation, renal impairment, coronary artery disease and others. Based on end user hospitals, blood and stem cell banks, others

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global heparin market based on various segments. It also provides market size and forecast estimates from year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The heparin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting heparin market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the heparin market in these regions.

MARKET PLAYERS

The reports cover key developments in the heparin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. Below mentioned is the list of few companies engaged in the heparin market.

The report also includes the profiles of key heparin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

1. GlaxoSmithKline plc
2. Pfizer, Inc.
3. Baxter
4. Leo Pharma A/S
5. Sanofi
6. Dr. Reddy's Laboratories Ltd.
7. Aspen Holdings
8. B. Braun Medical Inc.
9. Fresenius SE & Co. KGaA
10. EMD Millipore

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Heparin Market - By Type
1.3.2 Heparin Market - By Route of Administration
1.3.3 Heparin Market - By Application
1.3.4 Heparin Market - By End User
1.3.5 Heparin Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEPARIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEPARIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEPARIN MARKET - GLOBAL MARKET ANALYSIS
6.1. HEPARIN - GLOBAL MARKET OVERVIEW
6.2. HEPARIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HEPARIN MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. LOW MOLECULAR WEIGHT HEPARIN
7.3.1. Overview
7.3.2. Low Molecular Weight Heparin Market Forecast and Analysis
7.4. ULTRA-LOW MOLECULAR WEIGHT HEPARIN
7.4.1. Overview
7.4.2. Ultra-low Molecular Weight Heparin Market Forecast and Analysis
7.5. UNFRACTIONATED HEPARIN
7.5.1. Overview
7.5.2. Unfractionated Heparin Market Forecast and Analysis
8. HEPARIN MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INTRAVENOUS
8.3.1. Overview
8.3.2. Intravenous Market Forecast and Analysis
8.4. SUBCUTANEOUS
8.4.1. Overview
8.4.2. Subcutaneous Market Forecast and Analysis
9. HEPARIN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. VENOUS THROMBOEMBOLISM
9.3.1. Overview
9.3.2. Venous Thromboembolism Market Forecast and Analysis
9.4. ATRIAL FIBRILLATION
9.4.1. Overview
9.4.2. Atrial Fibrillation Market Forecast and Analysis
9.5. RENAL IMPAIRMENT
9.5.1. Overview
9.5.2. Renal Impairment Market Forecast and Analysis
9.6. CORONARY ARTERY DISEASE
9.6.1. Overview
9.6.2. Coronary Artery Disease Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. HEPARIN MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. BLOOD AND STEM CELL BANKS
10.4.1. Overview
10.4.2. Blood and stem cell banks Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. HEPARIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Heparin Market Overview
11.1.2 North America Heparin Market Forecasts and Analysis
11.1.3 North America Heparin Market Forecasts and Analysis - By Type
11.1.4 North America Heparin Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Heparin Market Forecasts and Analysis - By Application
11.1.6 North America Heparin Market Forecasts and Analysis - By End User
11.1.7 North America Heparin Market Forecasts and Analysis - By Countries
11.1.7.1 United States Heparin Market
11.1.7.1.1 United States Heparin Market by Type
11.1.7.1.2 United States Heparin Market by Route of Administration
11.1.7.1.3 United States Heparin Market by Application
11.1.7.1.4 United States Heparin Market by End User
11.1.7.2 Canada Heparin Market
11.1.7.2.1 Canada Heparin Market by Type
11.1.7.2.2 Canada Heparin Market by Route of Administration
11.1.7.2.3 Canada Heparin Market by Application
11.1.7.2.4 Canada Heparin Market by End User
11.1.7.3 Mexico Heparin Market
11.1.7.3.1 Mexico Heparin Market by Type
11.1.7.3.2 Mexico Heparin Market by Route of Administration
11.1.7.3.3 Mexico Heparin Market by Application
11.1.7.3.4 Mexico Heparin Market by End User
11.2. EUROPE
11.2.1 Europe Heparin Market Overview
11.2.2 Europe Heparin Market Forecasts and Analysis
11.2.3 Europe Heparin Market Forecasts and Analysis - By Type
11.2.4 Europe Heparin Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Heparin Market Forecasts and Analysis - By Application
11.2.6 Europe Heparin Market Forecasts and Analysis - By End User
11.2.7 Europe Heparin Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Heparin Market
11.2.7.1.1 Germany Heparin Market by Type
11.2.7.1.2 Germany Heparin Market by Route of Administration
11.2.7.1.3 Germany Heparin Market by Application
11.2.7.1.4 Germany Heparin Market by End User
11.2.7.2 France Heparin Market
11.2.7.2.1 France Heparin Market by Type
11.2.7.2.2 France Heparin Market by Route of Administration
11.2.7.2.3 France Heparin Market by Application
11.2.7.2.4 France Heparin Market by End User
11.2.7.3 Italy Heparin Market
11.2.7.3.1 Italy Heparin Market by Type
11.2.7.3.2 Italy Heparin Market by Route of Administration
11.2.7.3.3 Italy Heparin Market by Application
11.2.7.3.4 Italy Heparin Market by End User
11.2.7.4 Spain Heparin Market
11.2.7.4.1 Spain Heparin Market by Type
11.2.7.4.2 Spain Heparin Market by Route of Administration
11.2.7.4.3 Spain Heparin Market by Application
11.2.7.4.4 Spain Heparin Market by End User
11.2.7.5 United Kingdom Heparin Market
11.2.7.5.1 United Kingdom Heparin Market by Type
11.2.7.5.2 United Kingdom Heparin Market by Route of Administration
11.2.7.5.3 United Kingdom Heparin Market by Application
11.2.7.5.4 United Kingdom Heparin Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Heparin Market Overview
11.3.2 Asia-Pacific Heparin Market Forecasts and Analysis
11.3.3 Asia-Pacific Heparin Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Heparin Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Heparin Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Heparin Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Heparin Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Heparin Market
11.3.7.1.1 Australia Heparin Market by Type
11.3.7.1.2 Australia Heparin Market by Route of Administration
11.3.7.1.3 Australia Heparin Market by Application
11.3.7.1.4 Australia Heparin Market by End User
11.3.7.2 China Heparin Market
11.3.7.2.1 China Heparin Market by Type
11.3.7.2.2 China Heparin Market by Route of Administration
11.3.7.2.3 China Heparin Market by Application
11.3.7.2.4 China Heparin Market by End User
11.3.7.3 India Heparin Market
11.3.7.3.1 India Heparin Market by Type
11.3.7.3.2 India Heparin Market by Route of Administration
11.3.7.3.3 India Heparin Market by Application
11.3.7.3.4 India Heparin Market by End User
11.3.7.4 Japan Heparin Market
11.3.7.4.1 Japan Heparin Market by Type
11.3.7.4.2 Japan Heparin Market by Route of Administration
11.3.7.4.3 Japan Heparin Market by Application
11.3.7.4.4 Japan Heparin Market by End User
11.3.7.5 South Korea Heparin Market
11.3.7.5.1 South Korea Heparin Market by Type
11.3.7.5.2 South Korea Heparin Market by Route of Administration
11.3.7.5.3 South Korea Heparin Market by Application
11.3.7.5.4 South Korea Heparin Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Heparin Market Overview
11.4.2 Middle East and Africa Heparin Market Forecasts and Analysis
11.4.3 Middle East and Africa Heparin Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Heparin Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Heparin Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Heparin Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Heparin Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Heparin Market
11.4.7.1.1 South Africa Heparin Market by Type
11.4.7.1.2 South Africa Heparin Market by Route of Administration
11.4.7.1.3 South Africa Heparin Market by Application
11.4.7.1.4 South Africa Heparin Market by End User
11.4.7.2 Saudi Arabia Heparin Market
11.4.7.2.1 Saudi Arabia Heparin Market by Type
11.4.7.2.2 Saudi Arabia Heparin Market by Route of Administration
11.4.7.2.3 Saudi Arabia Heparin Market by Application
11.4.7.2.4 Saudi Arabia Heparin Market by End User
11.4.7.3 U.A.E Heparin Market
11.4.7.3.1 U.A.E Heparin Market by Type
11.4.7.3.2 U.A.E Heparin Market by Route of Administration
11.4.7.3.3 U.A.E Heparin Market by Application
11.4.7.3.4 U.A.E Heparin Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Heparin Market Overview
11.5.2 South and Central America Heparin Market Forecasts and Analysis
11.5.3 South and Central America Heparin Market Forecasts and Analysis - By Type
11.5.4 South and Central America Heparin Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Heparin Market Forecasts and Analysis - By Application
11.5.6 South and Central America Heparin Market Forecasts and Analysis - By End User
11.5.7 South and Central America Heparin Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Heparin Market
11.5.7.1.1 Brazil Heparin Market by Type
11.5.7.1.2 Brazil Heparin Market by Route of Administration
11.5.7.1.3 Brazil Heparin Market by Application
11.5.7.1.4 Brazil Heparin Market by End User
11.5.7.2 Argentina Heparin Market
11.5.7.2.1 Argentina Heparin Market by Type
11.5.7.2.2 Argentina Heparin Market by Route of Administration
11.5.7.2.3 Argentina Heparin Market by Application
11.5.7.2.4 Argentina Heparin Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HEPARIN MARKET, KEY COMPANY PROFILES
13.1. GLAXOSMITHKLINE PLC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAXTER
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. LEO PHARMA A/S
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SANOFI
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. DR. REDDY’S LABORATORIES LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ASPEN HOLDINGS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. B. BRAUN MEDICAL INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. FRESENIUS SE AND CO. KGAA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. EMD MILLIPORE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc
2. Pfizer, Inc.
3. Baxter
4. Leo Pharma A/S
5. Sanofi
6. Dr. Reddy's Laboratories Ltd.
7. Aspen Holdings
8. B. Braun Medical Inc.
9. Fresenius SE & Co. KGaA
10. EMD Millipore